2024 REVIEW: MIDCAP KA SAAL
Midcap 100 +23.86% vs Nifty +8.80% — aur Pharma ne +39.1% ke saath board jeeta
Published by The Retail Trader · DEC 31, 2024 · Performance Review
2024 largecap se door, bazaar ke chaude hisse mein paisa banane ka saal tha. Nifty ne +8.80% diya; usi saal Midcap 100 ne uska lagbhag teen guna diya.
INDEX LEVEL
Poora saal:
• Midcap 100 — +23.86%
• Nifty 500 — +15.16%
• Nifty 50 — +8.80%
• Sensex — +8.17%
• Bank Nifty — +5.32%, sabse peechhe
Ladder bilkul saaf hai: jitna chaudha basket, utna behtar return. Midcap ne Nifty se 15.1 point zyada diya — hamare 19-saal ke record mein ye teesra sabse bada midcap-favour spread hai (2023 ke 26.5 aur 2014 ke 24.5 ke baad).
SECTOR LEVEL
Calendar year 2024:
• Pharma — +39.1%
• Realty — +34.4%
• IT — +22.0%
• PSU Bank — +14.5%
• Metal — +8.4%
• Bank — +5.3%
• FMCG — -0.3%
• Media — -23.9%
Saat sectors positive, ek negative — 2026 ke ulta, jahan aath mein se chaar hi positive hain. 2024 ek broad-based saal tha, jahan galat sector chunna bhi zyada mehnga nahi padta tha (Media ko chhod kar).
AUR AAGE KYA HUA
Bank Nifty 2024 ka sabse kamzor index tha (+5.32%) aur 2025 mein sabse strong ban gaya (+17.15%). Pharma 2024 ka leader tha (+39.1%) aur 2025 mein -2.9% par aa gaya. Dono hi sector-rotation study ke us pattern ke andar hain: leadership tikti nahi.
Is article ke saare aankde The Retail Trader ke apne daily index database se compute kiye gaye hain, 24 July 2026 tak. Past performance future ka koi indication nahi hai, aur ye analysis sirf educational hai — koi buy ya sell recommendation nahi.